MS clinical trials aren’t conducted solely for the benefit of current patients. Multiple sclerosis trials also offer hope to people who will be diagnosed with this illness in the future. In fact, one of the recent breakthroughs would have never happened if it weren’t for these types of studies. Fingolimod, which is an oral treatment for MS, was the first of its kind. Before this, all medication had to be injected into the patient. Oral medication is a lot easier to take than injections as many people dislike having to inject themselves daily. Also, this new drug is one of the very first ones of its kind to slow the progression of MS. This, and other breakthroughs, would never have happened without research.

Another area of research helped doctors see the usefulness of MRIs when it comes to this disease. MRI scans are not only used to diagnose the disease …